Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | BlackRock Inc. BLK | 3,814,531 6.500% | 3,814,531 (New Position) | Filing History |
| 2023-12-11 09:09 am Sale | 2023-12-08 | 13G | Ventyx Biosciences, Inc. VTYX | FMR LLC | 322,615 0.546% | -7,281,726 (-95.76%) | Filing History |
| 2023-07-19 5:03 pm Purchase | 2023-07-07 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 8,556,866 14.600% | 34,242 (+0.40%) | Filing History |
| 2023-07-11 4:02 pm Sale | 2023-07-07 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 8,522,624 14.600% | -1,554,421 (-15.43%) | Filing History |
| 2023-04-10 09:37 am Purchase | 2023-04-06 | 13G | Ventyx Biosciences, Inc. VTYX | FMR LLC | 7,604,341 13.062% | 7,604,341 (New Position) | Filing History |
| 2023-04-07 5:13 pm Sale | 2023-04-06 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 10,077,045 17.300% | -1,747,098 (-14.78%) | Filing History |
| 2023-03-22 3:45 pm Sale | 2023-03-17 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 11,824,143 20.900% | -1,150,643 (-8.87%) | Filing History |
| 2023-03-02 4:56 pm Unchanged | 2023-02-24 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 12,974,786 22.900% | 0 (Unchanged) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | Citadel Advisors LLC | 3,788,795 6.700% | -102,278 (-2.63%) | Filing History |
| 2023-01-30 5:25 pm Sale | 2023-01-27 | 13D | Ventyx Biosciences, Inc. VTYX | venBio Global Strategic Fund III L.P. | 2,720,994 4.800% | -749,502 (-21.60%) | Filing History |
| 2022-12-30 5:05 pm Unchanged | 2022-12-30 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 12,974,786 22.900% | 0 (Unchanged) | Filing History |
| 2022-12-16 5:21 pm Sale | 2022-12-13 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 12,974,786 22.900% | -3,917,742 (-23.19%) | Filing History |
| 2022-12-15 5:00 pm Sale | 2022-12-13 | 13D | Ventyx Biosciences, Inc. VTYX | venBio Global Strategic Fund III L.P. | 3,470,496 6.100% | -1,541,040 (-30.75%) | Filing History |
| 2022-11-09 5:04 pm Sale | 2022-11-07 | 13D | Ventyx Biosciences, Inc. VTYX | Third Point LLC | 2,252,432 4.000% | -2,060,402 (-47.77%) | Filing History |
| 2022-09-20 9:25 pm Unchanged | 2022-09-17 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 16,892,528 30.000% | 0 (Unchanged) | Filing History |
| 2022-09-14 5:01 pm Unchanged | 2021-10-25 | 13D | Ventyx Biosciences, Inc. VTYX | venBio Global Strategic Fund III L.P. | 5,011,536 9.950% | 0 (Unchanged) | Filing History |
| 2022-02-14 06:26 am Purchase | 2021-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | Citadel Advisors LLC | 3,891,073 7.700% | 455,133 (+13.25%) | Filing History |
| 2021-11-04 5:11 pm Purchase | 2021-10-25 | 13D | Ventyx Biosciences, Inc. VTYX | Third Point LLC | 4,312,834 8.570% | 4,312,834 (New Position) | Filing History |
| 2021-11-04 4:21 pm Purchase | 2021-10-25 | 13G | Ventyx Biosciences, Inc. VTYX | Citadel Advisors LLC | 3,435,940 6.800% | 3,435,940 (New Position) | Filing History |
| 2021-11-04 4:15 pm Purchase | 2021-10-25 | 13D | Ventyx Biosciences, Inc. VTYX | venBio Global Strategic Fund III L.P. | 5,011,536 9.950% | 5,011,536 (New Position) | Filing History |